Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suresh Radhakrishnan

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Biotechnology and Applied Biochemistry|March 24, 2022
Computational analysis and in vitro evaluation of TMF 104, for its antioxidant, antimicrobial, and anticancer efficaciesAhmed Saif, Mesfer Al Shahrani, Mohammed Alshehri, et al.
Human Gene Therapy|May 26, 2010
Efficacy of oncolytic mutants targeting pRb and p53 pathways is synergistically enhanced when combined with cytotoxic drugs in prostate cancer cells and tumor xenograftsSuresh Radhakrishnan, Enrique Miranda, Maria Ekblad, et al.
Drug Development and Industrial Pharmacy|November 2, 2021
Structure activity evaluation and computational analysis identify potent, novel 3-benzylidene chroman-4-one analogs with anti-fungal, anti-oxidant, and anti-cancer activitiesGaffar Sarwar Zaman, Hossam Kamli, Suresh Radhakrishnan, et al.
European Journal of Immunology|June 6, 2007
Fast-tracked CTL: rapid induction of potent anti-tumor killer T cells in situKarin L Heckman, Erin L Schenk, Suresh Radhakrishnan, et al.
Oncology Research|June 12, 2023
Anticancer efficacy of 3-(4-isopropyl) benzylidene-8-ethoxy, 6-methyl, chroman-4-one (SBL-060), a novel, dual, estrogen receptor-Akt kinase inhibitor in acute myeloid leukemia cellsMesfer Al Shahrani, Prasanna Rajagopalan, Mohammad Abohassan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
Induction of a Th1 response from Th2-polarized T cells by activated dendritic cells: dependence on TCR:peptide-MHC interaction, ICAM-1, IL-12, and IFN-gammaSuresh Radhakrishnan, Karla R Wiehagen, Vesna Pulko, et al.
European Journal of Immunology|September 27, 2008
T-bet expression by dendritic cells is required for the repolarization of allergic airway inflammationKarin L Heckman, Suresh Radhakrishnan, Tobias Peikert, et al.
Plos One|April 29, 2009
Indirect recruitment of a CD40 signaling pathway in dendritic cells by B7-DC cross-linking antibody modulates T cell functionsSuresh Radhakrishnan, Rosalyn Cabrera, Kristina M Bruns, et al.
The Journal of Experimental Medicine|November 20, 2002
Cross-linking the B7 family molecule B7-DC directly activates immune functions of dendritic cellsLoc T Nguyen, Suresh Radhakrishnan, Bogoljub Ciric, et al.
Cancer Research|July 17, 2004
Immunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring antitumor immunitySuresh Radhakrishnan, Loc Tan Nguyen, Bogoljub Ciric, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Biotechnology and Applied Biochemistry|March 24, 2022
Computational analysis and in vitro evaluation of TMF 104, for its antioxidant, antimicrobial, and anticancer efficaciesAhmed Saif, Mesfer Al Shahrani, Mohammed Alshehri, et al.
Human Gene Therapy|May 26, 2010
Efficacy of oncolytic mutants targeting pRb and p53 pathways is synergistically enhanced when combined with cytotoxic drugs in prostate cancer cells and tumor xenograftsSuresh Radhakrishnan, Enrique Miranda, Maria Ekblad, et al.
Drug Development and Industrial Pharmacy|November 2, 2021
Structure activity evaluation and computational analysis identify potent, novel 3-benzylidene chroman-4-one analogs with anti-fungal, anti-oxidant, and anti-cancer activitiesGaffar Sarwar Zaman, Hossam Kamli, Suresh Radhakrishnan, et al.
European Journal of Immunology|June 6, 2007
Fast-tracked CTL: rapid induction of potent anti-tumor killer T cells in situKarin L Heckman, Erin L Schenk, Suresh Radhakrishnan, et al.
Oncology Research|June 12, 2023
Anticancer efficacy of 3-(4-isopropyl) benzylidene-8-ethoxy, 6-methyl, chroman-4-one (SBL-060), a novel, dual, estrogen receptor-Akt kinase inhibitor in acute myeloid leukemia cellsMesfer Al Shahrani, Prasanna Rajagopalan, Mohammad Abohassan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
Induction of a Th1 response from Th2-polarized T cells by activated dendritic cells: dependence on TCR:peptide-MHC interaction, ICAM-1, IL-12, and IFN-gammaSuresh Radhakrishnan, Karla R Wiehagen, Vesna Pulko, et al.
European Journal of Immunology|September 27, 2008
T-bet expression by dendritic cells is required for the repolarization of allergic airway inflammationKarin L Heckman, Suresh Radhakrishnan, Tobias Peikert, et al.
Plos One|April 29, 2009
Indirect recruitment of a CD40 signaling pathway in dendritic cells by B7-DC cross-linking antibody modulates T cell functionsSuresh Radhakrishnan, Rosalyn Cabrera, Kristina M Bruns, et al.
The Journal of Experimental Medicine|November 20, 2002
Cross-linking the B7 family molecule B7-DC directly activates immune functions of dendritic cellsLoc T Nguyen, Suresh Radhakrishnan, Bogoljub Ciric, et al.
Cancer Research|July 17, 2004
Immunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring antitumor immunitySuresh Radhakrishnan, Loc Tan Nguyen, Bogoljub Ciric, et al.
Pageof 3